SK

Sandhya Kancha

Active Director Director DIN 08579859
DIN 08579859 First appointment Dec 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Sandhya Kancha

Data last updated:

Sandhya Kancha is a Director at Medmore Pharma Private Limited (since 2019). The company operates in Pharma. Medmore Pharma Private Limited reported revenue of ₹93.1 Lakh (FY 2025).

DIN 08579859
Primary Designation Director
Industry Pharma
First Appointment 04 Dec 2019
Oldest Company Age 9 yrs
Largest company Medmore Pharma Private Limited · ₹93.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medmore Pharma Private Limited U24303TG2016PTC113051
Director04 Dec 20192016₹93.1 Lakh (FY 2025)Active

Board colleagues of Sandhya Kancha

NameDINCompanyDesignation
Venkatesh Kancha07657140Medmore Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medmore Pharma Private Limited
Premium access

Shareholding and investment profile for Sandhya Kancha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandhya Kancha

Sandhya Kancha currently holds 1 directorship: Medmore Pharma Private Limited (Director, since 04 Dec 2019, revenue ₹93.1 Lakh (FY 2025)).

Sandhya Kancha was first appointed on 04 Dec 2019 as Director at Medmore Pharma Private Limited.

The current boards of Sandhya Kancha's companies include Venkatesh Kancha (Medmore Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available